These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9894642)
1. [Incidence of atherosclerotic cardiovascular events in patients with chronic uremia: epidemiologic studies in Ile-de-France]. Jungers P; Nguyen Khoa T; Massy ZA; Man NK Nephrologie; 1998; 19(8):489-94. PubMed ID: 9894642 [TBL] [Abstract][Full Text] [Related]
2. Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: a multicentric study in the Ile de France district. Jungers P; Nguyen Khoa T; Massy ZA; Zingraff J; Labrunie M; Descamps-Latscha B; Man NK Nephrol Dial Transplant; 1999 Apr; 14(4):898-902. PubMed ID: 10328467 [TBL] [Abstract][Full Text] [Related]
3. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey. Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461 [TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Jungers P; Chauveau P; Bandin O; Chadefaux B; Aupetit J; Labrunie M; Descamps-Latscha B; Kamoun P Miner Electrolyte Metab; 1997; 23(3-6):170-3. PubMed ID: 9387110 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. [Demography and effects of chronic renal insufficiency in Ile-de-France]. Jungers P; Giraud E; Chauveau P; Geffriaud-Ricouard C; Man NK; Altman JJ; Jacobs C; Grünfeld JP Nephrologie; 1996; 17(8):429-34. PubMed ID: 9036365 [TBL] [Abstract][Full Text] [Related]
7. [Cardioprotection: an essential component for predialysis chronic renal failure treatment]. Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513 [TBL] [Abstract][Full Text] [Related]
8. [Incidence of chronic renal failure during 35 years at the Rijeka Clinical Hospital Center]. Orlić L; Matić-Glazar D; Vlahović A; Zivcić-Cosić S; Maleta I; Martinović BS; Racki S; Madzar Z Acta Med Croatica; 2004; 58(1):73-7. PubMed ID: 15125398 [TBL] [Abstract][Full Text] [Related]
9. Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Jungers P; Chauveau P; Descamps-Latscha B; Labrunie M; Giraud E; Man NK; Grünfeld JP; Jacobs C Nephrol Dial Transplant; 1996 Aug; 11(8):1542-6. PubMed ID: 8856208 [TBL] [Abstract][Full Text] [Related]
10. [Epidemiology of end-stage kidney failure in the Ile-de-France: a prospective cooperative study in 1998]. Jungers P; Choukroun G; Robino C; Taupin P; Labrunie M; Man NK; Landais P Nephrologie; 2000; 21(5):239-46. PubMed ID: 11068773 [TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Jungers P; Massy ZA; Nguyen Khoa T; Fumeron C; Labrunie M; Lacour B; Descamps-Latscha B; Man NK Nephrol Dial Transplant; 1997 Dec; 12(12):2597-602. PubMed ID: 9430858 [TBL] [Abstract][Full Text] [Related]
13. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study. Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072 [TBL] [Abstract][Full Text] [Related]
14. [Renal Epidemiology and Information Network: 2007 annual report ]. Couchoud C; Lassalle M; Stengel B; Jacquelinet C Nephrol Ther; 2009 Jun; 5 Suppl 1():S3-144. PubMed ID: 19524212 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?]. Lovcić V; Kes P; Zeljko R; Kusec V Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832 [TBL] [Abstract][Full Text] [Related]
16. [Renal replacement therapy by hemodialysis: an overview]. Jacobs C Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513 [TBL] [Abstract][Full Text] [Related]
17. Frequency and prognostic significance of QT prolongation in chronic renal failure patients. Voiculescu M; Ionescu C; Ismail G Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617 [TBL] [Abstract][Full Text] [Related]
18. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center]. Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685 [TBL] [Abstract][Full Text] [Related]
19. [Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies]. Pérez García R; Rodríguez Benítez P; Dall'Anesse C; Gómez Campderá F; Valderrábano F An Med Interna; 2001 Apr; 18(4):175-80. PubMed ID: 11496535 [TBL] [Abstract][Full Text] [Related]
20. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]